SOD1 and amyotrophic lateral sclerosis: This finding strengthens the idea that hSOD1 in skeletal muscle is a driver of pathogenesis in ALS [43,44,45,46] and identifies skeletal muscle DNMTs as disease-modifying therapeutic targets in ALS.